Tag Archives: NASDAQ:AMLN

GlaxoSmithKline Paying $3 Billion to End Fraud Charges

Posted on July 2, 2012 by Geoff Noir

GlaxoSmithKline (NYSE:GSK) health-care company decided to plead blameworthy and gave $3 billion to end US fines of fraud and malfunction to declare safety data, the US Justice Department reported on Monday.

The decision is the biggest linked to health-care scam …

Posted in Healthcare, Latest Headlines | Tagged Amylin, Arena Pharmaceuticals, Boston Scientific, Bristol-Myers Squibb, GlaxoSmithKline, GSK, Lincare, Merck, NASDAQ:AMLN, NASDAQ:ARNA, NASDAQ:LNCR, Novartis, NYSE:BMY, NYSE:BSX, NYSE:GSK, NYSE:MRK, NYSE:NVS, NYSE:PFE, Pfizer | Comments Off

Healthcare Sector; Two Vice Versa Stocks- NASDAQ:ACHN, NASDAQ:AMLN, NYSE:GS

Posted on April 24, 2012 by Thomas Vedder

Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) shares dropped as a Phase II study data for its escort hepatitis C treatment was believed unsatisfactory in light of the current success of peers. While lots of investment banks are optimistic about Achillion, JMP Group …

Posted in Healthcare, Latest Headlines | Tagged Achillion Pharmaceuticals, ACHN, AMLN, Amylin Pharmaceuticals, NASDAQ:ACHN, NASDAQ:AMLN | Comments Off

Soaring stocks and the reasons why (AMLN, VRML, PNR)

Posted on March 28, 2012 by Martin Timble

In this report: Amylin Pharmaceuticals (NASDAQ:AMLN), Vermillion (NASDAQ:VRML) and Pentair (NYSE:PNR).

Amylin Pharmaceuticals (NASDAQ:AMLN) has soared over 45 percent higher today after the reported surfaced that the company recently turned down a $3.5 billion buyout offer from Bristol-Myers Squibb. Bloomberg …

Posted in Latest Headlines, Reports | Tagged AMLN, Amylin Pharmaceuticals, NASDAQ:AMLN, NASDAQ:VRML, NYSE:PNR, Pentair, PNR, Vermillion, VRML | Comments Off

Soaring stocks and the reasons why (AMLN, PBY, TNB)

Posted on January 30, 2012 by Josie Middleton

In this report: Amylin Pharmaceuticals (NASDAQ:AMLN), Pep Boys-Manny, More & Jack (NYSE:PBY) and Thomas & Betts Corp. (NYSE:TNB).

Amylin Pharmaceuticals (NASDAQ:AMLN) has soared by more than 18 percent today after the company announced on Friday after the market closed that …

Posted in Latest Headlines, Reports | Tagged AMLN, Amylin Pharmaceuticals, More & Jack, NASDAQ:AMLN, NYSE:PBY, NYSE:TNB, PBY, Pep Boys-Manny, Thomas & Betts Corp., TNB | Comments Off

What the fuss JinkoSolar, Amylin Pharmaceuticals and Cray?

Posted on November 14, 2011 by Josie Middleton

In this report: JinkoSolar Holdings (NYSE:JKS), Cray Inc. (NASDAQ:CRAY) and Amylin Pharmaceuticals (NASDAQ:AMLN).

JinkoSolar Holdings (NYSE:JKS) dropped more than 13 percent on Monday after the company cut its shipment and revenue forecast for the third quarter and full year. The …

Posted in Latest Headlines, Reports | Tagged AMLN, Amylin Pharmaceuticals, analyst, company, CRAY, Cray Inc., cut, demand, Eli Lilly, forecast, full-year, going forward, guidance, IBM, JinkoSolar Holdings, JKS, megawatts, NASDAQ, NASDAQ:AMLN, NASDAQ:CRAY, Neutral, NYSE, NYSE:JKS, Outperform, price target, quarter, rating, report, revenue, Robert W. Baird, shipment, solar modules, supercomputer, University of Illinois, upgraded | Comments Off

Before the bell watchlist: ATP Oil & Gas, Diodes and Amylin Pharmaceuticals

Posted on November 9, 2011 by Josie Middleton

In this report: ATP Oil & Gas (NASDAQ:ATPG), Diodes Inc, (NASDAQ:DIOD) and Amylin Pharmaceuticals (NASDAQ:AMLN).

ATP Oil & Gas (NASDAQ:ATPG) has dropped by more than 14 percent today after the company reported another loss in the third quarter. The company …

Posted in Latest Headlines, Reports | Tagged adjusted, ALMN, Amylin Pharmaceuticals, analyst, Analysts, ATP Oil & Gas, ATPG, BMO Capital, company, DIOD, Diodes Inc, Market Perform, NASDAQ:AMLN, NASDAQ:ATPG, NASDAQ:DIOD, net income, Outperform, quarter, rating, reported, revenue, share, short, stock, trades, upgraded, Wall Street | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.